Chinese herba preparation for treating coronary heart disease and preparation method thereof

Abstract

The invention discloses a Chinese herba preparation for treating a coronary heart disease. The Chinese herba preparation is prepared by the following traditional Chinese medicines in parts by weight: 20-150 parts of salvia miltiorrhiza, 20-100 parts of kudzuvine root, 10-100 parts of ligusticum wallichii, 1-50 parts of radix ophiopogonis, 1-50 parts of ginseng, 1-50 parts of pseudo-ginseng, 1-30 parts of hawthorn, 1-30 parts of trichosanthes kirilowii maxim, 1-30 parts of allium macrostemon and 1-30 parts of flowers carthami. The Chinese herba preparation is an oral preparation, a sub-lingual preparation and an injection preparation. The Chinese herba preparation is in such ways of tablets, capsules, granules, soft capsules, pills, syrups and injections. The salvia miltiorrhiza, the kudzuvine root, the ligusticum wallichii, the radix ophiopogonis, the ginseng, the pseudo-ginseng, the hawthorn, the trichosanthes kirilowii maxim, the allium macrostemon and the flowers carthami are mixed for use in the Chinese herba preparation, so as to obviously alleviate stenocardia and improve myocardial ischemia. The invention further provides a preparation method of the Chinese herba preparation for treating the coronary heart disease. The salvia miltiorrhiza, the kudzuvine root, the ligusticum wallichii, the radix ophiopogonis, the ginseng, the pseudo-ginseng, the hawthorn, the trichosanthes kirilowii maxim, the allium macrostemon and the flowers carthami are crushed proportionally, extracted with ethanol, purified by macroreticular resin, condensed and dried to obtain dried powder and an extract, and finally the preparation is obtained.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine preparations, in particular to a traditional Chinese medicine preparation for treating coronary heart disease and a preparation method thereof. Background technique [0002] Coronary heart disease (CHD) is a common clinical disease, and is the second largest invisible killer after cancer, which seriously threatens human health. Various pathogenic factors can induce coronary heart disease. The main drugs for the treatment of coronary heart disease are: quinidine, procainamide, lidocaine, propafenone, propranolol, amiodarone, etc. Although these drugs have better effect in the treatment of coronary heart disease, the effect is rapid, However, it has strong side effects, while the toxic and side effects of traditional Chinese medicine are small. Therefore, the development of traditional Chinese medicine in recent years has attracted more and more attention. [0003] The research...

AI Technical Summary

Problems solved by technology

In the patent previously disclosed by the applicant (a preparation method and preparation of traditional Chinese medicine for the treatment of coronary heart disease and its effective chemical components, 201110330186.3), in the original prescription, Salvia miltiorrhiza promotes blood circulation and removes blood stasis, clears the menstrual flow and relieves pain; Qi disperses blood stasis to stop bleeding, reduces swelling and relieves pain; Ophiopogon japonicus nourishes yin and promotes body fluid; Ligusticum chuanxiong activates blood and promotes qi; it has a certain tonic effect on the deficiency of qi and blood, yin and yang, and also has certain effects on "blood stasis and stagnation of qi". The overall efficacy of the prescription is not significant, and needs to be improved urgently; and the prescription used in this patent needs to prepare active components for different medicinal materials, and then mix them. The operation is cumbersome, which is not conducive to the industrial production of the medicine and the improvement of labor productivity.

Images